Mouse cells contain the genetic information for multiple endogenous type-C RNA viruses. The mechanisms by which the cell controls expression of these naturally integrated viruses are not yet known. Recently, chemicals that inhibit protein synthesis have been sl-Gwn to induce a specific type-C virus at high frequenc, f rom BALB/c mouse embryo cells. In the present studie'z. virus activation in response to a representative trans"I;inal inhibitor, cycloheximide, is demonstrated to be I i ansient, with virus release primarily occurring within the first 12-24 hr following drug exposure. Analysis of virus-specific RNA in cells by molecular hybridization revealed an absolute increase in viral RNA concentration in cycloheximide-treated cells. This was blocked by simultaneous exposure of the cells to actinomycin D. Further, inhibition of RNA synthesis during but not subsequent to cycloheximide exposure prevented virus activation. These findings show that virus induction by cycloheximide requires de novo RNA synthesis during but not after drug exposure and suggest that the required RNA species may be that of the virus itself. The present results are consistent with the hypothesis that translational inhibitors prevent synthesis of a labile protein whose normal action is to inhibit viral RNA transcription or to cause degradation of viral RNA.
to be I i ansient, with virus release primarily occurring within the first 12-24 hr following drug exposure. Analysis of virus-specific RNA in cells by molecular hybridization revealed an absolute increase in viral RNA concentration in cycloheximide-treated cells. This was blocked by simultaneous exposure of the cells to actinomycin D. Further, inhibition of RNA synthesis during but not subsequent to cycloheximide exposure prevented virus activation. These findings show that virus induction by cycloheximide requires de novo RNA synthesis during but not after drug exposure and suggest that the required RNA species may be that of the virus itself. The present results are consistent with the hypothesis that translational inhibitors prevent synthesis of a labile protein whose normal action is to inhibit viral RNA transcription or to cause degradation of viral RNA.
Mouse cells contain the genetic information for multiple (1) (2) (3) (4) (5) (6) biologically distinguishable (4, 7) type-C RNA viruses. One of these endogenous viruses, induced from virus-negative cells in culture, has recently been shown to induce lymphatic leukemia in vivo (8) . Thus, study of the mechanisms involved in cellular regulation of naturally integrated type-C viral genes may be of importance in the development of methods to prevent expression of their malignant potential. In a recent report, several chemicals that inhibit different steps in protein synthesis in eukaryotes have been demonstrated to induce type-C virus at high frequency from virus-negative mouse cells (9) . In the present studies, the mechanism of action of one of these chemicals, cycloheximide, has been investigated. We report that cycloheximide causes an increase in the cellular concentration of type-C viral RNA and that this effect is dependent upon de novo RNA synthesis. Thus, cycloheximide affects the pathways involved in type-C virus release directly or indirectly at the level of viral RNA.
METHODS
Cultures were grown in Dulbecco's modification of Eagle's medium supplemented with 10% calf serum (Colorado Serum Co., Denver, Colo.). Cells included the continuous mouse lines, BALB/3T3 and BAL13/3T12-3 (10) , and the normal rat kidney (NRI) line (11 (7, 13, 14) . While assays for helper leukemia viruses invariably require multiple cycles of replication, transformation by murine sarcoma virus requires only a single cycle of infection (15) .
Thus, this technique provides one of the most sensitive and quantitative biologic techniques available for studying induction of type-C viruses. (9, 13, 14, 16) . Activated sarcoma virus was measured in tissue culture fluids as previously described (16) . An infectious center assay to quantitate the fraction of sarcoma virus-activated cells has also been reported (9, 16 formamide, 1 mM EDTA, 15 mM Tris -HC1, pH 7.5, and 150 mM NaCl. Hybridization was assayed with nuclease S-1 (19, 20) . (Fig. 2) . The return to the virus-restricted state following cycloheximide induction was much more rapid than has previously been shown with virus activation by another class of inducers, halogenated pyrimidines. With these latter drugs, type-C virus release from BALB/c cells begins within 24-48 hr and peaks at around 72 hr; however, the cells remain virus-activated at high frequency for several more days (12, 16) .
RESULTS

Induction of
Studies were performed to test the reinducibility of cultures after cycloheximide induction. As shown in Table 1 While these results do not exclude the possibility that selective drug toxicity to initially induced cells accounted for the transient release of virus, they argue that transient activation was not due to generalized toxicity affecting the whole cell population.
Virus-Specific RNA in Cycloheximide-Induced Cells. Cellular control of naturally-integrated type-C viral information might be exerted at the level of viral RNA transcription as in the case of the X repressor (21) or at a post-transcriptional level (see refs. 22 and 23). As a step in elucidating the processes involved, single-stranded DNA product of BALB: virus-2 was used to examine by molecular hybridization the effect of cycloheximide on the cellular concentration of virus-specific RNA. RNAs from untreated 13ALB/3T12-3 cells and from parallel cultures exposed to 10 jsg/ml of cycloheximide for 8 hr were hybridized to BALB: virus-2 [3HI DNA. As shown in Fig. 3 , RNA from untreated cells showed up to 60% homology to the viral DNA probe; the level of virus-specific RNA in the cells was not sufficient to achieve either complete or plateau hybridization with the highest amount of cell RNA tested (500 gg). The relative concentration of BALB: virus-2-homologous RNA in cycloheximide-treated cells was definitely increased (Fig. 3) 12 hr compared to that of noninduced cells is shown in the insert to Fig. 4 . The relative viral RNA levels can be determined from comparison of the slopes of the two curves. The approximately 3-fold increase in slope observed reflects a 3-fold increase in virus-specific RNA in the induced cells at this time.
The kinetics of Viral RNA expression in cells, as determined by this method, revealed a significant increase within 3 hr of drug exposure. At 16 hr, the peak in viral RNA was observed at a level 3-fold above that in untreated cultures. The decay in cell-associated viral RNA after drug removal was rapid, such that by 36 hr it had decreased by at least a factor of 2 from its peak concentration. By 72 hr, the viral RNA level was indistinguishable from that of untreated cells (data not shown).
These kinetics closely resembled the kinetics of virus release as determined by biologic assay (Fig. 2) .
It can also be seen in Fig. 4 that simultaneous treatment of cells with cycloheximide and an inhibitor of RNA synthesis, actinomycin D, effectively prevented the increase in virusspecific RNA observed with cycloheximide alone. These findings indicate that cycloheximide treatment is associated with an increase in the cellular concentration of BALB: virus-2 RNA, and that this effect can be blocked by inhibition of cellular IINA synthesis.
Time of RNTA Synthesis Required for Cyclohexirnide Induction. Studies were next performed to determine the time period during which RNA synthesis was necessary in order for cycloheximide to induce. In these experiments, cells were exposed to cycloheximide in the presence or absence of actinomycin D Exponential-phase BALB/3T12-3 cells growing in Bellco roller bottles were exposed to various drugs (stippled bar). At 12 hr, cultures were washed twice, and fresh medium was added. At designated times during and after drug treatment cells were harvested as described in the legend to Fig. 3 . Hybridization of cell RNA to BALB:virus-2 [3H]DNA product was performed as described in the Methods. Virus-specific RNA in cell relative to that at time zero in untreated BALB/3T12-3 cells, A; exposed to cycloheximide (10 l sg/ml.), 0; exposed to cycloheximide (10 /g/ml) plus actinomycin D (1 ,ug/ml), *. The insert shows a Wetmu~r-Davidson plot (28) of hybridization data with cellular RNAs from zero hour control (A) and 12 hr-cycloheximide-treated cells (@). The concentration of virus-specific RNA at the other points relative to that in untreated cells (zero time) was determined in an analogous way.
or cordycepin. The latter drug inhibits RNA synthesis by a mechanism different from that of actinomycin D (24) . At the concentrations of attinomycin D and cordycepin utilized, RNA synthesis was inhibited by more than 90% within 2 hr of cell exposure to either drug. As shown in Table 2 In an effort to exclude the possibility that cell toxicity associated with exposure to these chemicals might have influenced the above results, the colony-forming efficiencies of cells were compared under each set of treatment conditions. At the concentration. utilized, actinomycin D caused little or no additional impairment to cell growth (Table 2) . While there was obvious cell toxicity with simultaneous exposure to cycloheximide and cordycepin, the colony-forming efficiencies were no worse than those of cells sequentially treated with the same drugs. These findings tend to exclude the possibility that selective cell toxicity during simultaneous drug exposure was responsible for the block to virus release.
DISCUSSION
The discovery that inhibitors of protein synthesis efficiently induce a specific class of endogenous mouse type-C viruses has provided a potentially useful tool for analysis of cellular processes that normally restrict integrated type-C viral expression (9) . In the present report, a representative protein synthesis inhibitor, cycloheximide, has been shown to cause an increase in the level of virus-specific RNA in treated cells. The findings that virus-specific RNA rises only around 3-fold in the total cell population while the number of induced cells increases by 103 Cultures containing around 5 X 106 exponential phase K-BALB cells were exposed to 10 ug/ml of cycloheximide in the presence or absence of actinomycin D (1 pg/ml) or cordycepin (50 jug/ml) from 0 to 10 hr and washed three times with regular medium. The cells were then'treated with actinomycin or cordycepin, or were untreated from the 1Oth to 20th hour. At 20 hr, cell cultures were washed twice and transferred for infectious center assay, as described in the legend to Fig. 1 , or'for determination of colony-forming efficiency, as described in the Methods. accumulation of the control protein following return of protein synthesis within the cells.
The class of endogenous virus induced from BALB/c cells by cycloheximide is of biologic interest in that it appears to completely lack the ability to exogenously' infect cells in which it normally resides (7, 25) . There is evidence that similar viruses exist in cells'of other mouse strains, including those with both high and low incidence of naturally-occurring leukemia (7, (25) (26) (27) . These viruses have been termed "xenotropic" on the basis of the nonpermissiveness of mouse cells and the permissiveness of cells of other species for their growth (26) . Whether cycloheximide and other protein synthesis inhibitors will specifically induce such viruses from cells of other mouse strains and other species remains to be determined.
